THE FLU SEASON will be with us shortly. Please check the "News and Newsletters" link on the right for vaccination session dates and times.

 

DAILY WALK IN SERVICE from 8.30-11.00, Monday to Friday. NO APPOINTMENT NEEDED 
 
This service is generally for patients with a new problem. The service runs on a first come, first served basis where possible. 
   
PICK UP A LEAFLET AT RECEPTION

Prescription Charge £7.20 per item

 

8.45am to 11.45am 

These appointments are for pre-booked routine appointments only 
 
To book these appointments Telephone the practice between Monday – Friday, 8.00am to 6.30pm 
 

However,our Dispensary will be open for you to collect medications from 8.45-11.30 a.m.

 Home visits and urgent health problems will continue to be dealt with by the Out of Hours Service. To access this service call 0300 1115 717 

 

Find out about all of the free NHS services available to support you as you go try to give up smoking.

Stay safe in the sun, including sunscreens, sunburn relief, heat exhaustion, eczema and moles. Summer holidays are great fun for children, but can bring risks. Find out more

Would you like loads of tips and help to make changes for a healthier future? As part of Change4Life, you will receive tons of helpful information, recipes, tools, tips, and games for the kids.

AP - A leading virus expert urged health authorities around the world Sunday to stay vigilant even though the recent swine flu pandemic was less deadly than expected, warning that bird flu could spark the next global outbreak.

AP - Health officials in Chad say an outbreak of cholera in the Central African nation has killed at least 41 people.

AP - Could your kitchen at home pass a restaurant inspection?

AP - Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a yearslong federal investigation into its marketing of the top-selling, botulin-based drug.

AP - Scientists are reporting a major advance in diagnosing tuberculosis: A new test can reveal in less than two hours, with very high accuracy, whether someone has the disease and if it's resistant to the main drug for treating it.

AP - Editors of a top medical journal call Meridia "another flawed diet pill" and question whether it should stay on the market as a study shows it raises the risk of heart attack and stroke in people with heart problems.

Time.com - A new study finds that some users of the weight-loss pill Meridia may have an increased risk of heart attack or stroke

LiveScience.com - To most human males, the thought of your mother anywhere near your sex life is probably horrifying. Not so for the bonobo, one of our closest primate relatives. A new study confirms that hanging out with mom boosts male bonobos' chances of getting intimate with a fertile female.

HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

LiveScience.com - As schools start back into session around the country, some parents of young children face a difficult question: Send their little ones to kindergarten as soon as they become age-eligible, or hold them back in hopes that an additional year of maturity will give them an academic boost?

(MedPage Today) -- On July 15—a day after the FDA completed two days of hearings on rosiglitazone (Avandia)—a British advisory commission on drugs concluded that the product should be withdrawn from the market, according to an investigation conducted by BMJ.

WASHINGTON (MedPage Today) -- Several studies highlighting insurance issues were released this week, including one on federal programs for kids and two others focused on employer-provided medical coverage.

WASHINGTON (MedPage Today) -- The FDA approved a new formulation of the drug bimatoprost (Lumigan) in a 0.01% solution as a first-line treatment to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

(MedPage Today) -- Children with HIV who received standard childhood immunizations before starting on highly active antiretroviral therapy (HAART) could benefit from revaccination, a review suggests.

(MedPage Today) -- Adults with asthma and those who smoke should receive the 23-valent polysaccharide vaccine to prevent pneumococcal disease, according to new recommendations from the CDC.

WASHINGTON (MedPage Today) -- The consumer group Public Citizen is urging the Occupational Safety and Health Administration (OSHA) to regulate the work hours of resident physicians.

(MedPage Today) -- A combination of four factors appears to significantly increase the risk of opioid dependence among patients taking prescription painkillers, researchers have found.

(MedPage Today) -- Certain subgroups of patients with rheumatoid arthritis, particularly those who have low levels of IgG, are at risk for severe infections when treated with rituximab, French investigators found.

STOCKHOLM (MedPage Today) -- An investigational antiplatelet -- ticagrelor (Brilinta) -- emerged as a big winner from the five-day long European Society of Cardiology congress, but the buzz here focused instead on a trio of investigational oral anticoagulants -- dabigatran, rivaroxaban, and apixaban.

(MedPage Today) -- Wide-scale disclosure of clinical errors seems intuitively to be the ethical choice for hospitals and physicians, but researchers from the University of Washington suggest that disclosure should be decided on a case-by-case basis rather than a one-size-fits-all solution

Worldwide, H1N1 2009 virus transmission remains most intense in parts of India and in parts of the temperate southern hemisphere, particularly New Zealand and more recently in Australia.

The situation in New Zealand and India remains largely unchanged since the last update. Influenza H1N1 (2009) virus transmission remains locally intense in parts of India and New Zealand.

Influenza H1N1 (2009) virus transmission remains locally intense in parts of India and New Zealand.

The Emergency Committee held its ninth meeting by teleconference on 10 August 2010.

The world is now in the post-pandemic period. Based on knowledge about past pandemics, the H1N1 (2009) virus is expected to continue to circulate as a seasonal virus for some years to come. While the level of concern is now greatly diminished, vigilance on the part of national health authorities remains important. Such vigilance is especially critical in the immediate post-pandemic period, when the behaviour of the H1N1 (2009) virus as a seasonal virus cannot be reliably predicted.

As of 1 August 2010, worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 18449 deaths.

As of 25 July 2010, worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 18398 deaths.

As of 18 July 2010, worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 18366 deaths.

As part of regular monitoring of H1N1 pandemic influenza, the WHO is in close dialogue with public health experts in countries worldwide, specifically to determine whether H1N1 activity has returned to levels and patterns normally seen for seasonal flu.

As of 12 July, worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 18337deaths.